1. Home
  2. FDXF vs GMAB Comparison

FDXF vs GMAB Comparison

Compare FDXF & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FedEx Freight Holding Company Inc. Common Stock

FDXF

FedEx Freight Holding Company Inc. Common Stock

N/A

Current Price

$110.63

Market Cap

21.6B

ML Signal

N/A

GMAB

Genmab A/S ADS

BUY

Current Price

$37.88

Market Cap

20.3B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
FDXF
GMAB
Founded
1982
1999
Country
United States
Denmark
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6B
20.3B
IPO Year
2025
2008

Fundamental Metrics

Financial Performance
Metric
FDXF
GMAB
Price
$110.63
$37.88
Analyst Decision
Buy
Strong Buy
Analyst Count
14
11
Target Price
★ $161.71
$39.05
AVG Volume (30 Days)
1.4M
★ 2.9M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 4.38
N/A
Revenue
★ $8,795,000,000.00
N/A
Revenue This Year
$4.09
$23.71
Revenue Next Year
$5.20
$16.14
P/E Ratio
$25.49
★ $1.90
Revenue Growth
N/A
★ N/A
52 Week Low
$107.67
$23.62
52 Week High
$171.66
$40.17

Technical Indicators

Market Signals
Indicator
FDXF
GMAB
Relative Strength Index (RSI) 29.88 69.03
Support Level N/A $24.87
Resistance Level $135.70 N/A
Average True Range (ATR) 4.04 1.15
MACD -0.19 0.22
Stochastic Oscillator 17.89 62.48

Price Performance

Historical Comparison
FDXF
GMAB

About FDXF FedEx Freight Holding Company Inc. Common Stock

FedEx Freight Holding Co Inc is a North America-based less-than-truckload (LTL) transportation and freight services provider. Its service offerings - including Priority, Economy, and Direct shipping services - enable customers to select transportation options based on their needs. The company operates a network of vehicles and service locations across the U.S. states, Canada, Mexico, Puerto Rico, and the U.S. Virgin Islands, providing freight transportation and logistics services. It also utilizes data-driven technology and sales operations to support its transportation network and customer services.

About GMAB Genmab A/S ADS

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

Share on Social Networks: